February 24, 2016
Croise P et al. Endocr Relat Cancer 2016;23(4):2810293.
Cdc42 and Rac1 Activity Is Reduced in Human Pheochromocytoma and Correlates With FARP1 and ARHGEF1 Expression
You might also be interested by
Posters
Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
November 10, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Expands Proteomics Offering with Olink® Reveal Assay
August 6, 2025
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
Supporting Your Targeted Protein Degradation Strategies
April 1, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Joins Olink™ Certified Service Provider Network in China
February 13, 2025
Proteomics/Mass Spectrometry
More info